| scholarly article | Q13442814 |
| P50 | author | Ravi S. Menon | Q40832066 |
| Jean Theberge | Q43108302 | ||
| P2093 | author name string | Nagalingam Rajakumar | |
| Maria Densmore | |||
| Dick J Drost | |||
| Peter C Williamson | |||
| Richard W J Neufeld | |||
| Betsy Schaefer | |||
| Yousef Al-Semaan | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| patient | Q181600 | ||
| chronic schizophrenia | Q18967121 | ||
| P304 | page(s) | 2231-2233 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. | |
| P478 | volume | 160 |
| Q33941381 | 1H-MRS at 4 tesla in minimally treated early schizophrenia |
| Q34236416 | 3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine |
| Q49551461 | 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. |
| Q59800560 | A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia |
| Q49070894 | A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia |
| Q37419760 | A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia |
| Q31155440 | A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis |
| Q36960864 | Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania |
| Q31071498 | Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts |
| Q36767551 | Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla |
| Q42200896 | Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia |
| Q43538712 | Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study |
| Q37160608 | Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia |
| Q36234271 | Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia |
| Q31032036 | Antipsychotic drug action: targets for drug discovery with neurochemical imaging |
| Q36043389 | Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. |
| Q34193383 | Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. |
| Q35758433 | Auditory hallucinations: A review of the ERC "VOICE" project |
| Q39580232 | Beyond dopamine: glutamate as a target for future antipsychotics. |
| Q36420372 | Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction |
| Q30993265 | Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy |
| Q36113467 | Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia |
| Q38086791 | Deregulation of glutamate dehydrogenase in human neurologic disorders. |
| Q50657260 | Detection of glutamate, glutamine, and glutathione by radiofrequency suppression and echo time optimization at 7 tesla. |
| Q34351880 | Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders |
| Q47978821 | Effect of L-theanine on glutamatergic function in patients with schizophrenia. |
| Q24654374 | Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys |
| Q36579965 | Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction |
| Q37622674 | Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. |
| Q24803969 | Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients |
| Q60649876 | Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients |
| Q34661613 | Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine |
| Q46881160 | Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure. |
| Q36992322 | Glutamate and dopamine in schizophrenia: an update for the 21st century |
| Q30677120 | Glutamate and glutamine: a review of in vivo MRS in the human brain |
| Q34424470 | Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. |
| Q48343342 | Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum |
| Q33957510 | Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies |
| Q37215695 | Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study |
| Q30845062 | Glutamate-mediated excitotoxicity in schizophrenia: a review |
| Q41185372 | Glutamate/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits. |
| Q30732395 | Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings |
| Q37095356 | Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review |
| Q42544021 | Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? |
| Q48606111 | Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation. |
| Q33891806 | Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia |
| Q60242669 | Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study |
| Q57291671 | Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a [H]-spectroscopy twin study |
| Q35158156 | Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis |
| Q33516442 | Imaging genetics of structural brain connectivity and neural integrity markers |
| Q30854782 | Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation |
| Q37707322 | Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia |
| Q49028798 | Implementation issues of multivoxel STEAM-localized 1H spectroscopy |
| Q38300355 | In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors |
| Q28083121 | In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia |
| Q30873588 | In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia |
| Q37131013 | In vivo measurements of glutamate, GABA, and NAAG in schizophrenia |
| Q42616957 | Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression |
| Q46678012 | Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels |
| Q37958837 | MR spectroscopy in schizophrenia |
| Q30980196 | Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations |
| Q37425085 | Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders |
| Q31001850 | Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis |
| Q26865740 | Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies |
| Q34663830 | Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated rats |
| Q34429155 | Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics |
| Q35019147 | Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use |
| Q37148337 | N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia. |
| Q36068372 | N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives |
| Q33626101 | N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: a study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects |
| Q36471469 | N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia |
| Q43135401 | Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder |
| Q34246756 | Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond |
| Q30573043 | Neuroimaging studies in schizophrenia: an overview of research from Asia |
| Q30490982 | Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T. |
| Q30565982 | Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis |
| Q38209914 | Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries |
| Q45124893 | Nuclear magnetic resonance spectroscopy in glutaryl-CoA dehydrogenase deficiency |
| Q34372998 | Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders |
| Q30418647 | Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813. |
| Q33390364 | Prefrontal cortex glutamate correlates with mental perspective-taking |
| Q46470298 | Proton MRS in twin pairs discordant for schizophrenia |
| Q33955280 | Proton magnetic resonance spectroscopy in 22q11 deletion syndrome |
| Q37141400 | Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia |
| Q57300096 | Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of H-MRS Studies of Medial Prefrontal Myo-Inositol |
| Q42840560 | Quantifying the psychological effects of ketamine: from euphoria to the k-Hole |
| Q35662070 | RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients |
| Q34661581 | Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole |
| Q36323522 | Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia |
| Q39649554 | Regional distributions of brain glutamate and glutamine in normal subjects |
| Q30712278 | Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis |
| Q33429548 | Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders |
| Q34953049 | Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity |
| Q42131499 | Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia |
| Q35096566 | Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects |
| Q33923576 | Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response |
| Q30648464 | T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia |
| Q36298399 | Testing models of thalamic dysfunction in schizophrenia using neuroimaging. |
| Q37763856 | Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia. |
| Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
| Q46007929 | The effects of the glutamate antagonist memantine on brain activation to an auditory perception task. |
| Q37230904 | Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain |
| Q36817154 | Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive |
| Q51964590 | [Structural and functional brain changes in schizophrenic disorders. Indications of early neuronal developmental disturbances?]. |
Search more.